Traws Pharma, Inc. (TRAW) income statement
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.24+0.01 (+3.94%)
Close on Nov 18, 2026Market cap $3.73MP/E –Yield –
Traws Pharma, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -772.2%
- Net margin
- -773.0%
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.93
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 51.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?